Gland Pharma gets EIR for Dundigal facility

24 Aug 2023 Evaluate

Gland Pharma has received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for manufacturing facility at Dundigal, Hyderabad. USFDA had conducted inspection at the said manufacturing facility from July 03, 2023 to July 14, 2023. The inspection was concluded with (1) 483 Observation. 

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1653.35 3.95 (0.24%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×